MARKER THERAPEUTICS, INC. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2024-12-30: Federal exemption Rule 506(b); Types of securities offered Equity; SecurityToBeAcquired; Date of first sale 2024-12-23; Total offering amount $16,100,000.
- 2017-06-29: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; Date of first sale 2017-06-26; Total offering amount $6,190,002.
- 2016-09-09: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; Date of first sale 2016-08-10; Total offering amount $5,000,000.
- 2016-08-25: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2016-08-11; Total offering amount Indefinite.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2024-12-30 | Rule 506(b) | Equity; SecurityToBeAcquired | 2024-12-23 | $16,100,000 | $16,100,000 | $0 | 5 |
| 2017-06-29 | Rule 506(b) | Equity; OptionToAcquire | 2017-06-26 | $6,190,002 | $6,190,002 | $0 | 87 |
| 2016-09-09 D/A | Rule 506(b) | Equity; OptionToAcquire | 2016-08-10 | $5,000,000 | $3,135,195 | $1,864,805 | 46 |
| 2016-08-25 | Rule 506(b) | Equity; OptionToAcquire; SecurityToBeAcquired | 2016-08-11 | Indefinite | $0 | Indefinite | 11 |
| 2016-08-23 | Rule 506(b) | Equity; OptionToAcquire | 2016-08-10 | $5,000,000 | $2,426,195 | $2,573,805 | 29 |
| 2010-06-02 | Rule 506 | Equity; Debt; OptionToAcquire; SecurityToBeAcquired | 2010-05-24 | $1,275,000 | $1,275,000 | $0 | 4 |
| 2009-11-10 | Rule 506 | Equity; OptionToAcquire | 2009-09-28 | $700,000 | $700,000 | $0 | 3 |
| 2009-11-10 | Rule 506 | Debt; OptionToAcquire | 2009-08-31 | $350,000 | $350,000 | $0 | 1 |
| 2009-11-10 | Rule 506 | Debt; OptionToAcquire | 2009-02-02 | $135,000 | $135,000 | $0 | 10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |